Impact of Auditory Environments on Pain in Fibromyalgia: a 4×4 Crossover Trial
Key facts
- Who runs it
- Universidad de Granada
- Where
- Spain1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 88 people enrolled
- Started
- 4 Aug 2025
- Ended
- 31 Oct 2025
- Type of study
- Interventional, 4 groups
- Treatments tested
- Natural soundscape exposure
- Urban soundscape exposure
- Broadband sound exposure
- Blank tape attention placebo control
- Record updated
- 17 November 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- A diagnosis of fibromyalgia syndrome, documented in the medical record provided by the participant prior to enrollment
- Moderate or greater pain intensity during the preceding week, defined as a score higher than 3 on an 11-point Numeric Rating Scale
- Normal hearing confirmed by a hearing test, defined as a mean threshold of ≤ 20 dB HL at 0.125, 0.25, 0.5, 1, 2, 4, 6, and 8 kHz
- Ability to communicate in Spanish
- Provision of signed written informed consent to participate in the research
Who cannot take part
- Concurrent neuropathic or acute pain
- Changes in ongoing therapy during or within one month prior to study enrollment per participant self-reports
- A diagnosis of misophonia or auditory processing disorders, as documented in the participant's medical record
- Severe cognitive impairment, defined as a Mini-Mental State Examination score ≤ 17
- Severe psychiatric disorders in the symptomatic phase
- History of substance abuse in the past 12 months or current substance use disorder as reported by the participant
- Central nervous system disorders
- Any other serious or unstable medical condition that could interfere with study participation
- Known allergies or hypersensitivity to study materials
- Pregnancy, lactation, or being within three months postpartum at the time of study enrollment
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study examines whether different types of sounds can help reduce pain in people with fibromyalgia, a chronic condition that causes widespread pain and increased sensitivity to sensory experiences. Fibromyalgia affects approximately 2-3% of the global population and has limited treatment options. Recent research suggests that environmental sounds might have the capacity to influence pain perception, but their effects in chronic pain conditions remain largely unexplored. Such research could lead to new, non-invasive, sound-based approaches for managing fibromyalgia pain and inform the design of healthier acoustic environments for people with chronic pain conditions.
Read full original descriptionShow less
The study will compare four different sound environments: natural soundscapes (like birdsong and rainfall), urban soundscapes (like traffic and background conversation), broadband sounds (white or pink noise), and silence (as a neutral/control condition with intended placebo effect). Researchers want to know if these different sound environments can change how people with fibromyalgia experience pain and if some environmental sounds might be more helpful than others.
Each participant will experience all four sound conditions in a random order, with one session per week over four weeks. With this study design, each participant acts as their own control, which reduces differences between individuals and increases the reliability of the results. During each 20-minute session, participants will listen to the assigned sounds through a high-fidelity sound reproduction setup using headphones while lying comfortably on a padded therapy table in a controlled laboratory setting. Before and after each sound exposure, researchers measure pain intensity and sensitivity using standardized assessments to determine whether and how different sound environments, if any, might offer pain relief.
The 4 groups in the trial
- Sequence NBPUOther group
Participants assigned to this sequence receive natural soundscape exposure in Week 1, broadband sound exposure in Week 2, placebo control (blank tape) in Week 3, and urban soundscape exposure in Week 4. Each session lasts 20 minutes, with one-week washout intervals between sessions.
Treatment: Natural soundscape exposure, Urban soundscape exposure, Broadband sound exposure, and Blank tape attention placebo control
- Sequence UPBNOther group
Participants assigned to this sequence receive urban soundscape exposure in Week 1, placebo control (blank tape) in Week 2, broadband sound exposure in Week 3, and natural soundscape exposure in Week 4. Each session lasts 20 minutes, with one week washout intervals between sessions.
Treatment: Natural soundscape exposure, Urban soundscape exposure, Broadband sound exposure, and Blank tape attention placebo control
- Sequence BUNPOther group
Participants assigned to this sequence receive broadband sound exposure in Week 1, urban soundscape exposure in Week 2, natural soundscape exposure in Week 3, and placebo control (blank tape) in Week 4. Each session lasts 20 minutes, with one week washout intervals between sessions.
Treatment: Natural soundscape exposure, Urban soundscape exposure, Broadband sound exposure, and Blank tape attention placebo control
- Sequence PNUBOther group
Participants assigned to this sequence receive placebo control (blank tape) in Week 1, natural soundscape exposure in Week 2, urban soundscape exposure in Week 3, and broadband sound exposure in Week 4. Each session lasts 20 minutes, with one week washout intervals between sessions.
Treatment: Natural soundscape exposure, Urban soundscape exposure, Broadband sound exposure, and Blank tape attention placebo control
Results explained
A paper that names this trial, explained in plain words.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Impact of Auditory Environments on the Functioning of Pain Mechanisms in Fibromyalgia Syndrome: a Randomized, Triple-blind, Placebo-controlled 4×4 Crossover Trial
- Publications
- Record updated
- 17 November 2025